|
|
|
|
|
|
|
|
Editorial
With the growing number of cancer survivors, it is critical for us to consider toxicities that arise during treatment and do not resolve after treatment ends. Some symptoms continue to burden patients for many years after the cancer has been cured, and chemotherapy-induced peripheral neuropathy (CIPN) is a conspicuous example.....
..... We must be clinically attuned to the complaints our patients voice, and we must make a serious effort to develop prevention and treatment strategies that will reduce the burden of cancer treatment–associated toxicities.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.